The abstract is read at the publisher; the summary is JClub's.
Hist2Prot infers single-cell spatial proteomic profiles from hematoxylin and eosin histology, trained on ~51 million paired cells and validated across ~72 million additional cells.
- Why it matters: Routine clinical use of spatial proteomics is constrained by cost, technical complexity, and limited tissue coverage, leaving a gap for scalable, tissue-wide protein mapping.
- What they did: The deep learning framework was trained on a same-section G4X dataset and evaluated on internal tests, independent same-platform cohorts, and external cross-platform datasets using concordance with measured protein profiles.
- The result: In seven patient cohorts totaling 1,774 patients, virtual spatial proteomics improved biomarker, prognostic, and immunotherapy response prediction beyond hematoxylin and eosin morphology alone.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.